Dube Eric M
Insider CIK 1763494 · TVTX Chief Executive Officer, Director · RPHM Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-10-15 | 2026-10-19 | 200,000 | — | $0 | 160,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-10-15 | 2026-10-19 | 43,735 | — | $0 | 168,925 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-10-15 | 2026-10-19 | 78,400 | $55.02 | $4.31M | 432,886 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-10-15 | 2026-10-19 | 37,270 | $54.20 | $2.02M | 511,286 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-10-15 | 2026-10-19 | 128,065 | $52.97 | $6.78M | 548,556 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-10-15 | 2026-10-19 | 200,000 | $8.93 | $1.79M | 676,621 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-10-15 | 2026-10-19 | 43,735 | $26.88 | $1.18M | 476,621 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-17 | 2026-09-17 | 108,493 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-17 | 101,691 | $64.59 | $6.57M | 439,688 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-17 | 2026-09-17 | 108,493 | $23.34 | $2.53M | 541,379 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-17 | 6,802 | $64.95 | $441.8K | 432,886 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-17 | 2026-09-17 | 108,493 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-17 | 6,802 | $64.95 | $441.8K | 432,886 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-17 | 101,691 | $64.59 | $6.57M | 439,688 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-17 | 2026-09-17 | 108,493 | $23.34 | $2.53M | 541,379 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-16 | 2026-09-17 | 195,841 | — | $0 | 108,493 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-16 | 2026-09-17 | 195,841 | $23.34 | $4.57M | 628,727 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-16 | 2026-09-17 | 96,125 | $63.64 | $6.12M | 432,886 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-16 | 2026-09-17 | 99,716 | $63.26 | $6.31M | 529,011 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-16 | 2026-09-17 | 195,841 | — | $0 | 108,493 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-16 | 2026-09-17 | 96,125 | $63.64 | $6.12M | 432,886 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-16 | 2026-09-17 | 99,716 | $63.26 | $6.31M | 529,011 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-16 | 2026-09-17 | 195,841 | $23.34 | $4.57M | 628,727 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-17 | 95,666 | — | $0 | 304,334 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 270 | $65.31 | $17.6K | 432,886 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 3,102 | $63.64 | $197.4K | 433,156 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 28,796 | $62.66 | $1.80M | 436,258 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 63,498 | $61.99 | $3.94M | 465,054 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-15 | 2026-09-17 | 95,666 | $23.34 | $2.23M | 528,552 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-09-15 | 2026-09-17 | 95,666 | — | $0 | 304,334 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 270 | $65.31 | $17.6K | 432,886 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 3,102 | $63.64 | $197.4K | 433,156 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 28,796 | $62.66 | $1.80M | 436,258 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-09-15 | 2026-09-17 | 63,498 | $61.99 | $3.94M | 465,054 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-09-15 | 2026-09-17 | 95,666 | $23.34 | $2.23M | 528,552 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-05-06 | 2026-05-06 | 22,500 | $43.95 | $988.9K | 432,886 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2026-05-04 | 2026-05-06 | 45,000 | — | $0 | 45,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-05-04 | 2026-05-06 | 22,500 | — | $0 | 22,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-05-04 | 2026-05-06 | 22,500 | — | $0 | 455,386 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-15 | 2026-04-15 | 7,165 | $41.75 | $299.1K | 432,906 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-15 | 2026-04-15 | 20 | $42.66 | $853 | 432,886 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-15 | 2026-04-15 | 56,815 | $41.01 | $2.33M | 440,071 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2026-04-13 | 2026-04-15 | 64,000 | — | $0 | 496,886 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-04-01 | 2026-04-02 | 60,000 | — | $0 | 0 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-04-01 | 2026-04-02 | 60,000 | $15.46 | $927.6K | 492,886 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-01 | 2026-04-02 | 34,902 | $30.55 | $1.07M | 457,984 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-04-01 | 2026-04-02 | 25,098 | $31.46 | $789.6K | 432,886 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-02-20 | 2026-02-24 | 60,000 | — | $0 | 60,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-02-20 | 2026-02-24 | 60,000 | $30.10 | $1.81M | 432,886 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-02-20 | 2026-02-24 | 60,000 | $15.46 | $927.6K | 492,886 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-02-03 | 2026-02-03 | 66,452 | $32.06 | $2.13M | 466,521 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-02-03 | 2026-02-03 | 33,635 | $32.70 | $1.10M | 432,886 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2026-01-31 | 2026-02-03 | 303,600 | — | $0 | 303,600 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2026-01-31 | 2026-02-03 | 113,800 | — | $0 | 532,973 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-01-27 | 2026-01-27 | 51,865 | — | $0 | 120,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-01-27 | 2026-01-27 | 51,865 | $15.46 | $801.8K | 471,038 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-01-27 | 2026-01-27 | 51,865 | $30.10 | $1.56M | 419,173 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2026-01-23 | 2026-01-27 | 8,135 | — | $0 | 171,865 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2026-01-23 | 2026-01-27 | 8,135 | $15.46 | $125.8K | 427,308 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2026-01-23 | 2026-01-27 | 8,135 | $30.01 | $244.1K | 419,173 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-10-29 | 2025-10-30 | 27,128 | — | $0 | 180,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-10-29 | 2025-10-30 | 27,128 | $15.46 | $419.4K | 446,301 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-10-29 | 2025-10-30 | 27,128 | $30.12 | $817.1K | 419,173 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-10-28 | 2025-10-30 | 92,872 | — | $0 | 207,128 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-10-28 | 2025-10-30 | 92,872 | $15.46 | $1.44M | 512,045 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-10-28 | 2025-10-30 | 92,872 | $30.38 | $2.82M | 419,173 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-05-05 | 2025-05-05 | 18,924 | $21.05 | $398.4K | 419,173 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise deriv | 2025-05-02 | 2025-05-05 | 18,924 | — | $0 | 18,924 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | M Exercise | 2025-05-02 | 2025-05-05 | 18,924 | — | $0 | 438,097 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-02-11 | 2025-02-12 | 11,375 | $24.04 | $273.5K | 419,173 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-02-03 | 2025-02-04 | 50,691 | $20.21 | $1.02M | 430,548 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 260,000 | — | $0 | 260,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2025-01-31 | 2025-02-04 | 130,000 | — | $0 | 481,239 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2025-01-22 | 2025-01-23 | 10,736 | $19.46 | $208.9K | 351,239 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-09-09 | 2024-09-09 | 21,125 | $11.52 | $243.4K | 361,975 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2024-09-05 | 2024-09-09 | 32,500 | — | $0 | 383,100 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-02-01 | 2024-02-02 | 9,106 | $8.53 | $77.7K | 360,616 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-02-01 | 2024-02-02 | 10,016 | $8.86 | $88.7K | 350,600 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 360,000 | — | $0 | 360,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2024-01-31 | 2024-02-02 | 135,000 | — | $0 | 369,722 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2024-01-23 | 2024-01-25 | 7,873 | $8.96 | $70.5K | 234,722 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-09-05 | 2023-09-05 | 4,455 | $14.71 | $65.5K | 242,595 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2023-08-31 | 2023-09-05 | 9,900 | — | $0 | 247,050 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | A Award deriv | 2023-06-06 | 2023-06-08 | 17,500 | — | $0 | 17,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-02-01 | 2023-02-02 | 8,196 | $22.25 | $182.4K | 237,150 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 32,500 | — | $0 | 32,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 260,000 | — | $0 | 260,000 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2023-01-31 | 2023-02-02 | 97,500 | — | $0 | 245,346 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-01-24 | 2023-01-26 | 6,442 | $21.50 | $138.5K | 147,846 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2023-01-05 | 2023-01-06 | 5,625 | $20.75 | $116.7K | 154,288 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | A Award deriv | 2022-06-01 | 2022-06-03 | 17,500 | — | $0 | 17,500 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-02-10 | 2022-02-11 | 4,832 | $27.84 | $134.5K | 159,913 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 37,848 | — | $0 | 37,848 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 169,552 | — | $0 | 169,552 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-01-31 | 2022-02-02 | 4,813 | $27.40 | $131.9K | 164,745 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2022-01-31 | 2022-02-02 | 37,848 | — | $0 | 169,558 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-01-24 | 2022-01-26 | 7,873 | $24.98 | $196.7K | 131,710 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-01-05 | 2022-01-06 | 10,361 | $29.84 | $309.2K | 141,722 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-01-05 | 2022-01-06 | 2,139 | $30.48 | $65.2K | 139,583 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 4,832 | $30.43 | $147.0K | 152,083 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-08-17 | 2021-08-17 | 7,836 | $17.12 | $134.2K | 156,915 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-08-13 | 2021-08-17 | 17,500 | — | $0 | 164,751 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-03 | 4,780 | $14.35 | $68.6K | 147,251 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-06-01 | 2021-06-03 | 4,782 | $14.89 | $71.2K | 152,031 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-08 | 2021-02-09 | 4,813 | $31.58 | $152.0K | 156,813 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-05 | 2021-02-09 | 4,813 | $31.41 | $151.2K | 161,626 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-03 | 2021-02-03 | 2,406 | $28.91 | $69.6K | 148,939 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-02-03 | 2021-02-05 | 17,500 | — | $0 | 166,439 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-02 | 2021-02-02 | 2,406 | $30.75 | $74.0K | 151,345 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-02-02 | 2021-02-02 | 6,328 | $29.60 | $187.3K | 153,751 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-01-31 | 2021-02-02 | 15,000 | — | $0 | 160,079 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2021-01-21 | 2021-01-25 | 212,600 | — | $0 | 212,600 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award deriv | 2021-01-21 | 2021-01-28 | 212,660 | — | $0 | 212,660 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | A Award | 2021-01-21 | 2021-01-25 | 57,260 | — | $0 | 145,079 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-01-06 | 2021-01-07 | 3,438 | $27.01 | $92.9K | 87,819 | SEC↗ |
| TVTX Travere Therapeutics, Inc. | S Sale | 2021-01-05 | 2021-01-07 | 3,438 | $26.65 | $91.6K | 91,257 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-09-21 | 2020-09-22 | 9,240 | $19.28 | $178.1K | 96,260 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-09-21 | 2020-09-22 | 1,565 | $19.29 | $30.2K | 94,695 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-09-18 | 2020-09-22 | 3,000 | — | $0 | 105,500 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-09-18 | 2020-09-22 | 25,000 | — | $0 | 102,500 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-01-31 | 2020-01-31 | 300,000 | — | $0 | 300,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-01-31 | 2020-01-31 | 35,000 | — | $0 | 35,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2020-01-31 | 2020-01-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2020-01-31 | 2020-01-31 | 35,000 | — | $0 | 77,500 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-01-08 | 2020-01-08 | 3,750 | $15.14 | $56.8K | 42,500 | SEC↗ |
| RTRX Retrophin, Inc. | S Sale | 2020-01-07 | 2020-01-08 | 3,750 | $13.94 | $52.3K | 46,250 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-01-04 | 2019-01-08 | 400,000 | — | $0 | 400,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award deriv | 2019-01-04 | 2019-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RTRX Retrophin, Inc. | A Award | 2019-01-04 | 2019-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |